INS and fatty liver disease: Additional mechanisms that contribute to the reduction in hepatic steatosis include suppression of caloric intake, inhibition of de novo lipogenesis in the liver, and increased insulin sensitivity in adipose and muscle tissue, which promotes glucose uptake in peripheral organs [70].